1,401 results on '"Leemans, C. René"'
Search Results
52. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review
53. Mental healthcare utilization among head and neck cancer patients: A longitudinal cohort study.
54. MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma:development, testing and comparison with genomic prognostic signatures
55. A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma
56. Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma
57. Predictive value of quantitative 18F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma
58. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers
59. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review
60. Critical Issues in Head and Neck Oncology
61. Supplementary Table S2 from The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics
62. Table S2 from Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
63. Data from The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics
64. Supplementary figures from The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics
65. Figure S3 from Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
66. Data from Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
67. supplementary figure S1 from Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients
68. Supplementary Table S3 from Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes
69. Legends to supplementary figures from The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics
70. Supplementary tables and figure legends from Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients
71. Data from Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients
72. Supplementary Data from Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
73. Supplementary Table 2 from Identification of Lethal microRNAs Specific for Head and Neck Cancer
74. Data from Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC
75. Supplementary Data from Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell Carcinomas
76. Supplementary Figures from Identification of Lethal microRNAs Specific for Head and Neck Cancer
77. Supplementary Table 3 from Identification of Lethal microRNAs Specific for Head and Neck Cancer
78. Supplementary Table 4 from Identification of Lethal microRNAs Specific for Head and Neck Cancer
79. Supplementary Table 1 from Identification of Lethal microRNAs Specific for Head and Neck Cancer
80. Data from Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
81. Supplementary Table 5 from Identification of Lethal microRNAs Specific for Head and Neck Cancer
82. The Change in Social Eating over Time in People with Head and Neck Cancer Treated with Primary (Chemo)Radiotherapy: The Role of Swallowing, Oral Function, and Nutritional Status
83. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
84. Intravoxel incoherent motion magnetic resonance imaging in head and neck cancer: A systematic review of the diagnostic and prognostic value
85. The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
86. Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer
87. Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition
88. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
89. Swallowing and Voice Outcomes following Treatment of Hypopharyngeal Cancer: The Need for Supervised Rehabilitation
90. Follow-up of oral cancer patients: three uneventful years may be enough
91. Quality assurance in head and neck surgery: special considerations to catch up
92. Patient-reported physical activity and the association with health-related quality of life in head and neck cancer survivors
93. Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?
94. Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape
95. Evaluation of vascular features of vocal cords proposed by the European Laryngological Society
96. Management of the brachial plexus in head and neck cancer
97. Caregiver Burden, Psychological Distress and Quality of Life among Informal Caregivers of Patients with Head and Neck Cancer: A Longitudinal Study
98. External validation of an MR-based radiomic model predictive of locoregional control in oropharyngeal cancer
99. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification
100. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.